3/14/2024 | 17021110 | PHARMACEUTICAL RAW MATERIAL: RESPITOSE SV003 LACTOSE MONOHYDRATE USP-NF PH.EUR. JP.CH.P | XXXXXXXXXX | 100 | KG | 16961.741935 | Netherland | KPAF |
3/5/2024 | 17021110 | PHARMACETICAL RAW MATARIAL ALLOPATHIC PHARMA GRADE:
RESPITOSE SV003 LACTOSE MONOHYDRATE USP-NF PH EUR JP CH .P QTY 150 KGS BATCH NO 10CP4ST MFG DT: 03-12-2023 EXP DT: 03-11-2026 | XXXXXXXXXX | 150 | KG | 25256.431386 | Netherland | KPAF |
2/22/2024 | 17021110 | PHARMACEUTICAL RAW MATERIAL: RESPITOSE SV003 LACTOSE MONOHYDRATE USP-NF PH.EUR. JP CH | XXXXXXXXXX | 100 | KG | 16791.43 | Netherland | KPAF |
2/16/2024 | 17021110 | PHARMACEUTICAL RAW MATERIAL
(RESPITOSE (R) ML001 LACTOSE MONOHYDRATE USP-NF-PH.EUR.JP.CH.P | XXXXXXXXXX | 1500 | KG | 153381.53 | Netherland | LPAF |
2/12/2024 | 17021110 | PHARMACEUTICAL RAW MATERIAL ( ALLOPATHIC ) RESPITOSE SV003 LACTOSE MONOHYDRATE USP-NF PH.EUR. JP CH.P ADC: E-8302864647386 DT: 12-02-2024 | XXXXXXXXXX | 50 | KG | 8359.65 | Netherland | KPAF |
1/30/2024 | 17021110 | PHARMACEUTICAL RAW MATERIAL (RESPITOSE ML001 LACTOSE MONOHYDRATE) | XXXXXXXXXX | 150 | KG | 25252.05 | Netherland | IPAF |
11/13/2023 | 17021110 | PHARMACEUTICAL RAW MATERIAL: RESPITOSE® SV003 LATOSE® MONOHYDRATE USP-NF PH.EUR. JPCH.P
PH.EUR. JP CH.P | XXXXXXXXXX | 300 | KG | 49036.476738 | Netherland | KPAF |
11/13/2023 | 17021110 | PHARMACEUTICAL RAW MATERIAL
(RESPITOSE (R) ML001 LACTOSE MONOHYDRATE USP-NF-PH.EUR.JP.CH.P | XXXXXXXXXX | 1500 | KG | 162316.83917 | Netherland | LPAF |
10/27/2023 | 17021110 | PHARMACEUTICAL RAW MATERIAL ( ALLOPATHIC ) RESPITOSE SV003 LACTOSE MONOHYDRATE USP-NF PH.EUR. JP CH.P ADC: E-7067364646183 DT: 20-10-2023 | XXXXXXXXXX | 50 | KG | 8187.930664 | Netherland | KPAF |
9/19/2023 | 17021110 | PHARMACEUTICAL RAW MATERIAL: RESPITOSE® SV003 LATOSE® MONOHYDRATE USP-NF PH.EUR. JP CH.P | XXXXXXXXXX | 200 | KG | 33107.430497 | Netherland | KPAF |